Filing Details

Accession Number:
0001209191-23-005717
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-31 16:45:28
Reporting Period:
2023-01-30
Accepted Time:
2023-01-31 16:45:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204424 Lloyd Carney C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-30 1,376 $320.08 5,474 No 4 S Direct
Common Stock Disposition 2023-01-30 1,000 $320.70 4,474 No 4 S Direct
Common Stock Disposition 2023-01-30 324 $321.84 4,150 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Carney's company approved trading plan under Rule 10b5-1.
  2. Mr. Carney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $320.08 (range $319.40 to $320.38).
  4. Open market sales reported on this line occurred at a weighted average price of $320.70 (range $320.43 to $321.31).
  5. Open market sales reported on this line occurred at a weighted average price of $321.84 (range $321.54 to $322.23).